Looking at options history for SolarEdge Technologies (SEDG) we detected 21 trades. If we consider the specifics of each trade, it is accurate to state that 61% of the investors opened trades with ...

We gleaned this information from our observations today when Benzinga's options scanner highlighted 10 extraordinary options activities for SolarEdge Technologies. This level of activity is out of the ...

Learn more about whether ACM Research, Inc. or SolarEdge Technologies, Inc. is a better investment based on AAII's A+ ...

The stackable battery ranges 4.9 kWh to 19.6 kWh per unit while the inverter is available in ranges from 3.8 kW to 13 kW. The ...

SolarEdge Technologies (SEDG) concluded the recent trading session at $34.71, signifying a +1.76% move from its prior day's close.

Shares of solar power systems company SolarEdge (NASDAQ:SEDG) fell 5.8% in the morning session after key competitor Enphase Energy (ENPH) announced the U.S. launch of a new, technologically advanced ...

Auvik excels at automated network discovery and provides excellent visibility for IT teams managing distributed networks. While the pricing can escalate quickly for larger deployments, its ease of use ...

UPPSALA, SE / ACCESS Newswire / September 9, 2025 / Senzime AB (publ) (STO:SEZI)(OTCQX:SNZZF) - today announced that the Japanese Society of Anesthesiology (JSA) has published updated clinical guideli ...

The Department of Transportation (DOTr) has signed a memorandum of understanding (MOU) with the Department of Budget and Management (DBM) aimed at strengthening the monitoring and evaluation of ...

On 1 September 2025, Enersize announced that the Company had entered into a Letter of Intent (LOI) with Pure Positioning AB (publ) ("PPAB") regarding a potential acquisition of the company. PPAB has t ...

Aug 28 (Reuters) - The U.S. Food and Drug Administration said on Thursday it is recommending additional, earlier scans to monitor brain swelling prior to the third infusion for patients with Alzheimer ...

Phase III Randomized Study of 4 Weeks of High-Dose Interferon-α-2b in Stage T2bNO, T3a-bNO, T4a-bNO, and T1-4N1a-2a (microscopic) Melanoma: A Trial of the Eastern Cooperative Oncology Group–American ...